Sex and Age Factors of Mental Development of Children Born to Mothers with Epilepsy

Mother’s epilepsy is a risk factor for the neurocognitive development of the child, since it belongs to a group of chronic diseases and constant medication, even during pregnancy, is a Author for correspondence.vital for patients with epilepsy. It carries various risks, which include intrauterine growth restrictions, congenital malformations, negative effects on cognitive functions and an increased risk of mental retardation of the child. That is why the bulk of research is focused on the effect of certain antiepileptic drugs on the physical development of the child. However, researchers rarely carry out comprehensive assessment of the influence of prenatal, perinatal and age-related factors of the child’s development, and this area remains unstudied. This article presents the results of a study of sex and age factors of mental development and adaptation of children born to mothers with epilepsy. The study involved 176 people: 88 children aged from 3 to 9 years and their mothers suffering from epilepsy. As a result, it was found that the male fetus was more vulnerable to prenatal influences: boys had more pronounced disorders of mental development (motor awkwardness, hyperactivity, attention deficit, oral speech disorders) and adaptation (socialization disorders, emotional-volitional disorders, aggressiveness and oppositional reactions, behavior problems). Some of disorders of mental development (delay in the development of speech, praxis and logical thinking) were compensated with child’s age and secondary disorders — adaptation problems (socialization disorders, somatic and internalization problems, isolation and anxiety) became more significant. Disorders of mental development in children are caused not only by the toxic effects of medication taken by the mother, but also depend on the form and severity of mother’s epilepsy before and during pregnancy, her concomitant diseases, as well as the type of feeding of the child in the first year of life.

Adab, N., Kini, U., Vinten, J., Ayres, J., Baker, G., Clayton-Smith, J., Coyle, H., Fryer, A., Gorry, J., Gregg, J., Mawer, G., Nicolaides, P., Pickering, L., Tunnicliffe, L., Chadwick, D. W. (2004). The longer term outcome of children born to mothers with epilepsy. Journal of Neurology, Neurosurgery, and Psychiatry,  75, 1575–1583.

Artama, M., Ritvanen, A., Gissler, M., Isojärvi, J., Auvinen, A. (2006). Congenital structural anomalies in offspring of women with epilepsy — a population-based cohort study in Finland. International Journal of Epidemiology,  35 (2), 280–287.

Artama, M., Auvinen, A., Raudaskoski, T., Isojarvi, I., Isojarvi, J. (2005). Antiepileptic drug use of women with epilepsy and congenital malformations in offspring. Neurology,  64, 1874–1878.

Badalyan, L. O., Zavadenko, N. N., Uspenskaya, T. Yu. (1993). Attention deficit syndromes in children (review). Review of psychiatry and medical psychology named after V. M. Bekhterev,  3, 74–90. (In Russian)

Bakushkina, N. I., Rogacheva, T. V. (2019). Analysis of neurocognitive development of children with moderate and mild prematurity at an early age using Bailey scales (third edition). SibScript,  1 (77), 56–63. (In Russian)

Bakushkina, N. I. (2022). Trajectories of the development of neurocognitive functions in premature infants aged 3 to 36 months, depending on the stages of synaptogenesis:  PhD thesis. St. Petersburg. (In Russian)

Banach, R., Boskovic, R., Einarson, T., Koren, G. (2010). Long-term developmental outcome of children of women with epilepsy, unexposed or exposed prenatally to antiepileptic drugs: A meta-analysis of cohort studies. Drug Safety,  33 (1), 73–79.

Bech, L. F., Polcwiartek, C., Kragholm, K., Andersen, M. P., Rohde, C., Torp-Pedersen, C., Nielsen, J., Hagstrom, S. (2018). In utero exposure to antiepileptic drugs is associated with learning disabilities among offspring. Journal of Neurology, Neurosurgery, and Psychiatry,  89 (12), 1324–1331.

Blotière, P. O., Raguideau, F., Weill, A., Elefant, E., Perthus, I., Goulet, V., Rouget, F., Zureik, M., Coste, J., Dray-Spira, R. (2019). Risks of 23 specific malformations associated with prenatal exposure to 10 antiepileptic drugs. Neurology, 93 (2), 167–180. https://doi.org/10.1212/WNL.0000000000007696

Blüml, S., Wisnowski, J., Nelson, M., Paquette, L., Panigrahy, A. (2014). Metabolic maturation of white matter is altered in preterm infants. PLoS ONE,  9 (1), e85829.

Canger, R., Battino, D., Canevini, M. P., Fumarola, C., Guidolin, L., Vignoli, A., Mamoli, D., Palmieri, C., Molteni, F., Granata, T., Hassibi, P., Zamperini, P., Pardi, G., Avanzini, G. (1999). Malformations in offspring of women with epilepsy: A prospective study. Epilepsia,  40 (9), 1231–1236.

Chutko, L. S., Palchik, A. B. (2012). Attention deficit hyperactivity disorder (causes, diagnosis, treatment).  St. Petersburg, Costa Publ. (In Russian)

Deblay, M. F., Vert, P., André, M. (1982). Children of epileptic mothers. La Nouvelle pressemédicale,  11, 173–176.

Glozman, J. M. (2019). Practical neuropsychology. Experience of working with children with learning difficulties,  J. M. Glozman (ed.), Moscow, Genesis Publ. (In Russian)

Hirano, T., Fujioka, K., Okada, M., Iwasa, H., Kaneko, S. (2004). Physical and psychomotor development in the offspring born to mothers with epilepsy. Epilepsia,  45 (8), 53–57.

Kapellou, O., Counsell, S., Kennea, N., Dyet, L., Saeed, N., Stark, J. (2006). Abnormal cortical development after premature birth shown by altered allometric scaling of brain growth. PLoS Medicine,  3 (8), e265.

Karlov, V. A. (2019). Epilepsy in children and adult women and men. A guide for doctors.  Second edition. Moscow, Binom Publ. (In Russian)

Koch, S., Titze, K., Zimmermann, R. B., Schröder, M., Lehmkuhl, U., Rauh, H. (1999). Long-term neuropsychological consequences of maternal epilepsy and anticonvulsant treatment during pregnancy for school-age children and adolescents. Epilepsia,  40 (9), 1237–1243.

Kozhokaru, A. B., Karlov, V. A., Zhidkova, I. A., Serkina, A. V. (2010). Stigmas of dysembriogenesis and physical development in children born to mothers suffering from epilepsy. Epilepsy and paroxysmal states,  2 (2), 25–31. (In Russian)

Kruglova, E. A. (2016). Gender differences in the manifestations of attention deficit hyperactivity disorder of younger schoolchildren. Bulletin of the Ivanovo State University. Series: Natural, Social Sciences,  1, 27–30. (In Russian)

Larina, I. V. (2021). Topical issues of pregnancy management in patients with epilepsy. Bulletin of Epileptology,  1, 36–47. (In Russian)

Lodhi, S., Agrawal, N. (2012). Neurocognitive problems in Epilepsy. Advances in Psychiatric Treatment, 18, 232–240. https://doi.org /10.1192/apt.bp.110.007930

Meador, K. J., Baker, G. A., Browning, N., Cohen, M. J., Bromley, R. L., Clayton-Smith, J., Kalayjian, L. A., Kanner, A., Liporace, J. D., Pennell, P. B., Privitera, M., Loring, D. W. (2013). Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): A prospective observational study. Lancet Neurology,  12 (3), 244–252.

Morrow, J., Russell, A., Guthrie, E., Parsons, L., Robertson, I., Waddell, R., Irwin, B., McGivern, R. C., Morrison, P. J., Craig J. (2006). Malformations risks of antiepileptic drugs in pregnancy: A prospective study from the UK Epilepsy and Pregnancy Register. Journal of Neurology, Neurosurgery, and Psychiatry,  77, 193–198.

Oyen, N., Vollset, S. E., Eide, M. G., Bjerkedal, T., Skjærven, R. (2007). Maternal epilepsy and offsprings’ adult intelligence: A population-based study from Norway. Epilepsia,  48, 1731–1738.

Semenovich, A. V. (2017). Neuropsychological correction in childhood. The method of substitutive ontogenesis:  textbook. 10th ed. Moscow, Genesis Publ. (In Russian)

Sher, S. A. (2011). Teratogenic effect of drugs on the body of an unborn child at the stage of intrauterine development, Pediatric Pharmacology,  8 (6), 57–60. (In Russian)

Tau, G. Z., Peterson, B. S. (2010). Normal development of brain circuits. Neuropsychopharmacology,  35 (1), 147–168.

Titze, K., Koch, S., Helge, H., Lehmkuhl, U., Rauh, H., Steinhausen, H.-C. (2008). Prenatal and family risks of children born to mothers with epilepsy: Effects on cognitive development. Developmental Medicine and Child Neurology,  50 (2), 117–122.

Tomson, T., Battino, D., Bonizoni, E, Craig, J., Lindhout, D., Perucca, E., Sabers, A., Thomas, S., Vajda, F. (2015). NEAD Study Group. Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): A prospective observational study. Neurology,  85 (10), 866–872.

Vajda, F. J., Hitchcock, A., Graham, J., Solinas, C., O’Brien, T. J., Lander, C. M., Eadie, M. J. (2006). Fetal malformations and seizure control: 52 months data of the Australian Pregnancy Registry. European Journal of Neurology,  13, 645–654.

Webb, S. J., Monk, C. S., Nelson, C. A. (2001). Mechanisms of postnatal neurobiological development: Implications for human development. Developmental Neuropsychology,  19 (2), 147–171.

Wide, K., Henning, E., Tomson, T., Winbladh, B. (2002). Psychomotor development in preschool children exposed to antiepileptic drugs in utero. Acta Paediatrica,  91, 409–414.

Yakunina, A. V., Poverennova, I. E., Ananyeva, S. A. (2015). Teratogenic effect of antiepileptic drugs according to the registers of congenital malformations in the Samara region. Proceedings of the Samara Scientific Center of the Russian Academy of Sciences,  17 (5-2), 433–438. (In Russian)

Yakunina, A. V., Poverennova, I. E., Kalinin, V. A., Ananyeva, S. A. (2017), Intellectual development of children born to mothers with epilepsy. Neurology, neuropsychiatry, psychosomatics, Epilepsy,  spec. iss. 1, 54–57. (In Russian)

Zavadenko, N. N. (2005). Hyperactivity and attention deficit in childhood. Moscow, Yurait Publ. (In Russian)